Careers  |  Sign In  |  Register  |   Twitter

Drug Shown to Help Hemoglobin Levels in CKD Patients

Reuters reports that Rockwell Medical‘s “late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease [CKD].” The study tested Soluble Ferric Pyrophosphate (SFP) in adults suffering from CKD, and found that it successfully replaces iron “that is lost during a dialysis treatment and is delivered via the fluids used in dialysis.” The trial demonstrates that the “frequency and severity of adverse events experienced by patients on SFP and those on a placebo were comparable.”

Read the article published by Reuters.